$0.253
-0.004 (-1.60%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
VTGN 相似圖表分析預測
Alphio's VTGN stock price prediction model matches the current Vistagen Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.25 (-0.34%). The 1-week path is $0.27 (+4.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Vistagen Therapeutics Inc 股票嗎？
Vistagen Therapeutics is currently not a strong buy. The stock is trading at $0.2529, and while it has shown a 3.65% increase over the past five days, it has a staggering year-to-date decline of 62.75%. The RSI is at 48.935, indicating a neutral position, and the forward P/E ratio is 0, reflecting uncertainty in future earnings. The main risk is the recent trial failure which caused a significant drop in stock price, highlighting potential volatility ahead.
VTGN 股價於 Friday 收在 $0.25，此前下跌 -1.60%
Vistagen Therapeutics Inc (VTGN) last closed at $0.2529, losing -1.60%. These facts feed the 1-day and 1-week VTGN price prediction above.
分析師一致預期
Vistagen Therapeutics Inc（VTGN）：買進 1、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Vistagen Therapeutics Inc（VTGN）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 VTGN 最接近的股票，依相似度排序。
VTGN 季節性分析
Historically the probability of a positive August return for VTGN is 3.17%. October offers the highest probability of a positive month at 50.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。